Effect of chronic para-chlorophenylalanine treatment on convulsive-seizure reactions.
The effect of chronic para-chlorphenylalanine (PCPA) treatment was investigated in two different seizure models: the pentylenetetrazole (PTX) seizure model in rats and the kindled seizures from rabbit amygdala. Chronic PCPA treatment (21 days) in male albino rats caused a progressive decrease in the 5-hydroxytryptamine (5-HT) brain level between the 1st and the 7th day of PCPA administration. Then the 5-HT level remained low until the end of the experiment. On the background of the low 5-HT level there occurred changes in PTZ convulsive reactions: after the 3rd day of PCPA treatment the convulsive-seizure reactivity was significantly increased and after the 7th, 14th and 21st day the increased seizure reactivity performed only as a tendency, though the 5-HT level was still low. Chronic PCPA treatment (16 days) of rabbits delayed the development of the behavioural kindled seizures. This treatment also reduced the duration of bioelectrical seizures until the 8th day of treatment, especially in the motor cortex. The observed different effect of the chronic PCPA treatment in both seizure models: pentylenetetrazole in rats and kindling in rabbits might be explained by essential differences in the origin and mechanisms of development of the two seizure models.
D000679:Amygdala / Q000502:physiology; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D004558:Electric Stimulation; D010134:Fenclonine / Q000494:pharmacology*; D007700:Kinetics; D008297:Male; D010433:Pentylenetetrazole; D011817:Rabbits; D051381:Rats; D012640:Seizures / Q000139:chemically induced / Q000503:physiopathology*; D012701:Serotonin / Q000378:metabolism*
D012701:Serotonin; D010134:Fenclonine; D010433:Pentylenetetrazole